Relative risk of various endocrinopathies associated with the use of chemoimmunotherapy for triple-negative breast cancer: A systematic review and meta-analysis

N Jahan; S Wongsaengsak; Sakshi Singal; S Rehman; F Hardwicke; Charles W. Jones

Relative risk of various endocrinopathies associated with the use of chemoimmunotherapy for triple-negative breast cancer: A systematic review and meta-analysis

N Jahan
, S Wongsaengsak
, Sakshi Singal
, S Rehman
, F Hardwicke
, Charles W. Jones

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	American English
Title of host publication	CANCER RESEARCH
Publisher	CANCER RESEARCH
Volume	81
Edition	4
State	Published - 2021

Cite this

@inproceedings{b1a3eb2af8694de5bcfd717ca8ecdd3c,

title = "Relative risk of various endocrinopathies associated with the use of chemoimmunotherapy for triple-negative breast cancer: A systematic review and meta-analysis",

author = "N Jahan and S Wongsaengsak and Sakshi Singal and S Rehman and F Hardwicke and Jones, \{Charles W.\}",

year = "2021",

language = "American English",

volume = "81",

booktitle = "CANCER RESEARCH",

publisher = "CANCER RESEARCH",

edition = "4",

}

TY - GEN

T1 - Relative risk of various endocrinopathies associated with the use of chemoimmunotherapy for triple-negative breast cancer: A systematic review and meta-analysis

AU - Jahan, N

AU - Wongsaengsak, S

AU - Singal, Sakshi

AU - Rehman, S

AU - Hardwicke, F

AU - Jones, Charles W.

PY - 2021

Y1 - 2021

M3 - Conference contribution

VL - 81

BT - CANCER RESEARCH

PB - CANCER RESEARCH

ER -